Sort
8,912 grants matching “sars cov 2”
Center for Excellence in Host Pathogen Interactions
$2,073,225David S. Bradley · University Of North Dakota · P20 · FY2022 · GM
Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization
$2,071,529Kenneth D Stuart · Seattle Children'S Hospital · U19 · FY2022 · AI
Cardiovascular Genomics and Bioinformatics projects
$2,064,651Andrew Johnson · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL
Molecular Approaches To Antiviral Development For Viral Hepatitis and Other Viral Diseases
$2,063,799T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
Center for Excellence in Host Pathogen Interactions
$2,063,090David S. Bradley · University Of North Dakota · P20 · FY2021 · GM
Integrative Immunogen Design and Testing
$2,060,891Erica Ollmann Saphire · Brigham And Women'S Hospital · P01 · FY2023 · AI
ALZHEIMERS RESEARCH PROJECT: Developing Extraceullar Vesicle biomarkers for clinical and preclinical AD/ADRD
$2,057,404Dimitrios Kapogiannis · National Institute On Aging · ZIA · FY2024 · AG
Early detection and inference for emerging infectious agents in data-sparse settings
$2,056,250Sen Pei · Columbia University Health Sciences · R35 · FY2025 · GM
Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses
$2,044,217Fred R Hirsch · Icahn School Of Medicine At Mount Sinai · U54 · FY2022 · CA
Emerging respiratory viruses - pathogenesis and countermeasures
$2,042,870Emmie De Wit · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
A Follow-up Study for Causes of Cancer in Black Women
$2,042,803Julie R Palmer · Boston University Medical Campus · U01 · FY2023 · CA
Center for Excellence in Host Pathogen Interactions
$2,038,822David S. Bradley · University Of North Dakota · P20 · FY2023 · GM
A Follow-up Study for Causes of Cancer in Black Women
$2,035,759Julie R Palmer · Boston University Medical Campus · U01 · FY2024 · CA
The COVID-19 pandemic: Impact on mental health and HIV outcomes
$2,035,602Keri Nicole Althoff · Johns Hopkins University · RF1 · FY2023 · MH
Paramyxoviruses as Vaccine Vectors Against Highly Pathogenic Viruses
$2,034,822Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
CoVPN 3006: A randomized controlled study to assess SARS-CoV-2 infection, viral shedding, and subsequent potential transmission in university students immunized with Moderna COVID-19 Vaccine
$2,034,708Peter B. Gilbert · Fred Hutchinson Cancer Research Center · UM1 · FY2021 · AI
Applying Bioinformatics to Research in Immune, Muscle, and Bone Diseases
$2,033,275Hong-Wei Sun · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIC · FY2025 · AR
Mechanism and Regulation of Eukaryotic Protein Synthesis
$2,032,638Thomas E Dever · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2022 · HD
Role of O-glycosylation in Animal Development
$2,025,039Kelly G Ten Hagen · National Institute Of Dental & Craniofacial Research · ZIA · FY2021 · DE
Kaiser Washington Vaccine and Treatment Evaluation Unit - DMID 21-0012
$2,014,564Lisa A Jackson · Kaiser Foundation Research Institute · UM1 · FY2021 · AI
Mechanism and Regulation of Eukaryotic Protein Synthesis
$2,009,782Thomas E Dever · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2023 · HD
Clinical and Informatics Research on Large Clinical Databases
$2,008,861Clement McDonald · National Library Of Medicine · ZIA · FY2023 · LM
Significant expansion of the SNPRC ABSL3 capability in the wake of COVID-19
$2,000,000Larry S. Schlesinger · Texas Biomedical Research Institute · P51 · FY2020 · OD
Wastewater Detection of COVID-19
$2,000,000Jeff Wenzel · Missouri State Dept/ Health & Senior Srv · U01 · FY2021 · DA
Prospective Cohort to Assess Novel and Repeated SARS-CoV-2 Infection and COVID-19 Illness within a US State or Region
$2,000,000National Cancer Institute · Y01 · FY2021 · CA